RxDoctor Payments DataLook up a doctor →

William Edmonson, MD

Pulmonary Disease · Tupelo, MSNPI 1528031077

Payments from drug & device makers

$15,372in general payments, 2019–2025

Across 661 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Intuitive Surgical$2K
  • GSK$2K
  • Boehringer Ingelheim$1K
  • Harmony Biosciences LLC$967
  • Jazz Pharmaceuticals Inc.$532
  • plus $6K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca82$2,304
Intuitive Surgical7$2,134
GSK129$1,596
Boehringer Ingelheim87$1,395
Harmony Biosciences LLC31$967
Jazz Pharmaceuticals Inc.25$532
Insmed, Inc.22$527
Inspire Medical Systems, Inc.8$468
Mallinckrodt Hospital Products Inc.18$447
Merck21$401
Regeneron Healthcare Solutions, Inc.17$373
Novartis23$362
Sanofi16$341
Actelion Pharmaceuticals US, Inc.17$296
ANI Pharmaceuticals, Inc.13$295
Bayer13$255
Genentech USA, Inc.15$222
Mylan Specialty L.p.11$208
La Jolla Pharmaceutical Company9$195
Takeda Pharmaceuticals U.S.A., Inc.9$172
Mallinckrodt Enterprises LLC4$148
Baxter Healthcare5$147
United Therapeutics Corporation10$143
Livanova USA, Inc.1$126
Sunovion Pharmaceuticals Inc.12$117
Medtronic(2 entities)2$103
Amgen6$98
Astellas Pharma US Inc5$96
Pulmonx Corporation4$92
Portola Pharmaceuticals, LLC5$92
Philips North America LLC4$78
Grifols USA, LLC3$78
Body Vision Medical Inc.1$67
Veran Medical Technologies, Inc.1$60
3b Medical, Inc.3$59
Axsome Therapeutics, Inc.3$58
Gilead4$54
Verona Pharma, Inc.2$41
Fisher & Paykel Healthcare Inc2$39
Boston Scientific1$24
Chiesi USA, Inc.1$23
Viatris Specialty LLC1$19
Ambu Inc.1$19
AbbVie1$17
Aerin Medical Inc.1$17
Resmed Corp1$16
Liquidia Technologies, Inc.1$15
Tetraphase Pharmaceuticals, Inc.1$14
Johnson & Johnson1$14
Monaghan Medical Corporation1$12

How this compares

$15,372 in reported general payments places this provider in the 80th percentile of 101 pulmonary disease providers in Mississippi.

See all pulmonary disease providers in Mississippi →

Medicare billing

Part B allowed, 2024
$219,792
Medicare patients
1,179
Services billed
2,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Tupelo

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →